At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
09939 KINTOR PHARMA-B
Trading 03-02 11:12:42
2.550
-0.130
-4.85%
High2.730
Low2.550
Vol1.63M
Open2.640
D1 Closing2.680
Amplitude6.72%
Mkt Cap1.27B
Tradable Cap1.27B
Total Shares499.00M
T/O4.31M
T/O Rate0.33%
Tradable Shares499.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
GENFLEET-B's GFH375 Receives Breakthrough Therapy Designation in China for KRAS G12D-Mutant NSCLC
Healthcare Sector Shows Divergence as Scarce Leaders Gather, HK Stock Connect Medical ETF (159137) Rises for Fourth Consecutive Session at Low Levels! Institutions Hint at Hong Kong's "Spring Festival Rally"
Kintor Pharmaceutical Ltd is an investment holding company primarily engaged in the research and development of innovative medicine products. The Company's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The Company has two core drugs in the dermatology field, KX-826 and GT20029. The Company's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.